醫藥股普遍造好跑贏大市 百濟神州、康方生物及信達生物續升9.5%-11% 惟雲頂新耀回吐14%
阿思達克 07-04 15:44
恆指今天在新經濟股主導反覆續彈101點或0.5%，現報19,406，總成交額僅698億元。
然而，里昂指，內地近期醫保數據顯示消費力佳，對醫療股行業增長前景樂觀。醫藥股今天普遍升逾2%跑贏大市；信達生物(01801.HK)三連漲兼曾一舉重越10天及20天線(30.7元及33.35元)，最高見33.55元，現報33.3元，急漲11%。康方生物-B(09926.HK)反覆升破50天線(38.1元)，高低見40.55元/35.85元，現報40.05元，續升近11%。
獲建銀國際預期表現強於大盤看158元的百濟神州(06160.HK)由七個月低位連彈第二天兼重越10天線(110.95元)，今天高低見119.3元/107.2元，現報118.5元，續彈9.5%。
維亞生物(01873.HK)、聯邦制藥(03933.HK)、諾誠健華-B(09969.HK)、歌禮製藥-B(01672.HK)、開拓藥業-B(09939.HK)、騰盛博藥-B(02137.HK)、3D MEDICINES-B(01244.HK)、再鼎醫藥-B(09688.HK)升約4%-8%，後兩者跑贏，股價高見104元及24.65元，現報102.9元及24.5元，分別回升6.5%及續升8.2%。
華領醫藥-B(02552.HK)三連升兼重越20天線(1.78元)，最高見1.91元，現報1.86元，續升6.9%。
四大藍籌藥股全面升逾2%-6.5%，創新藥聖羅萊獲藥品註冊證書兼獲國金維持「買入」評級的翰森(03692.HK)升幅最大，股價三連升兼重越20天及50天線，最高見13.98元(剛為百天線)，現報13.84元，續升6.8%。藥明生物(02269.HK)反覆續升3.8%報39.55元；藥明康德(02359.HK)反覆續升2.7%報65.55元，股價重越20天線(65.4元)。
然而，雲頂新耀-B(01952.HK)終止連日升勢，股價近五個月高位回吐14%報20.45元，考驗10天線(20.4元)。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
More Content
CS Hotline: +852 3018 4526
Trading days: 24 hours | Non-trading days: 9:00-18:00
